Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries
A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fundSeveral rapid, point-of-care antigen tests are being assessed by WHO for Emergency Use Listing (EUL)Agreements between the…
